A carregar...
Safety and efficacy of pembrolizumab in a patient with advanced melanoma on haemodialysis
Patients with end-stage renal disease present with a distinct challenge in oncology. Many anticancer drugs and their metabolites are excreted by the kidney, but data to guide dose and schedule adjustments in renal dialysis are scant. Pembrolizumab is an anti-programmed cell death protein 1 monoclona...
Na minha lista:
| Publicado no: | BMJ Case Rep |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5051445/ https://ncbi.nlm.nih.gov/pubmed/27659911 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2016-216426 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|